Sheel Biotech Q2 Results 2026 (FY27): Revenue ₹50.56 Cr, EBITDA margin 11.67%
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
Based on Sheel Biotech Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Revenue from Operations (H1 FY2027): ₹50.56 Crore vs. EBITDA for H1 FY2027: ₹589.76 Lakhs, up 208.31% YoY from ₹191.29 Lakhs.
From Sheel Biotech Ltd's Q2 FY27 earnings-call transcript · updated 17 Nov 2026.
How did Sheel Biotech's revenue grow in the September 2026 quarter?
- Revenue from Operations (H1 FY2027): ₹50.56 Crore vs. ₹21.85 Crore (H1 FY2026), up 131.39% YoY (Page 5)
- Total Income (H1 FY2027): ₹50.88 Crore vs. ₹21.99 Crore (H1 FY2026), up 131.33% YoY (Page 5)
- Outlook:
2 more points from Sheel Biotech Ltd's call on revenue
Create a free account to keep reading this call
What happened to Sheel Biotech's margins in Q2 FY27?
See what Sheel Biotech Ltd said on profitability & margins — free account, 30 seconds.
What capex is Sheel Biotech planning?
- Blueberry Commercial Expansion (FY27–28): Expand contracted farm acreage, scale tissue culture production of blueberry plants domestically, strengthen cold chain and post-harvest handling capacity dedicated to berries, deepen FPO network deployment for contract blueberry farming.
- Status: Institutional orders secured for blueberry projects in Jammu & Kashmir and Himachal Pradesh (H1 FY27).
- Infrastructure: Pilkhuwa, UP facility includes a live blueberry demo farm and offers integrated Greenhouse + Aeroponic + Hydroponic + Packhouse facilities.
- Tissue culture production capacity: 1.5 Crore plants/year, re-orientable to blueberries as demand scales.
2 more points from Sheel Biotech Ltd's call on capex
Create a free account to keep reading this call
Is Sheel Biotech raising money or cutting debt?
See what Sheel Biotech Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Sheel Biotech's order book?
- The presentation reports a combined announced project value of ₹35.92 Crore comprising:
- ₹21.39 Crore Jammu & Kashmir Precision Farming Project focused on setting up 5 Centres of Excellence for Precision Farming across 5 districts of Jammu & Kashmir, executed on a turnkey basis.
- ₹14.53 Crore Blueberry Growing Infrastructure Project, including infrastructure and growing systems for blueberry cultivation.
- Received Letter of Allotment from J&K Agro Industries Development Corporation Limited (JKAIDCL) for the Jammu & Kashmir Precision Farming Project.
2 more points from Sheel Biotech Ltd's call on order book
Create a free account to keep reading this call
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Sheel Biotech Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Sheel Biotech Ltd Q2 FY27 results?
Revenue from Operations (H1 FY2027): ₹50.56 Crore vs. EBITDA for H1 FY2027: ₹589.76 Lakhs, up 208.31% YoY from ₹191.29 Lakhs.
What is Sheel Biotech Ltd share price analysis?
Sheel Biotech Ltd currently shows a neutral. The stock trades at a P/E of 8.3 with a market cap of ₹124 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sheel Biotech Ltd planning capital expenditure?
Blueberry Commercial Expansion (FY27–28): Expand contracted farm acreage, scale tissue culture production of blueberry plants domestically, strengthen cold chain and post-harvest handling capacity ded.
Keep Sheel Biotech Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
